Overview A Clinical Pharmacology Study of TS-142 in Patients With Obstructive Sleep Apnea Hypopnea. Status: Recruiting Trial end date: 2021-12-31 Target enrollment: Participant gender: Summary A study to evaluate the respiratory safety of TS-142 in patients with mild obstructive sleep apnea hypopnea. Phase: Phase 1 Details Lead Sponsor: Taisho Pharmaceutical Co., Ltd.